Arthur Py

Aisel Health - the clinical operating system for psychiatry Psychiatry doesnt have a caring problem. It has a capacity problem. Clinicians are buried in documentation and fragmented information, while patients wait months for care that should be available the moment they need it. Aisel closes that gap. We sit at the workflow layer around every consultation - recording, structuring notes, and pulling together the scattered pieces of a patients history into one clear, complete picture. From referrals and prior records to hundreds of pages of case documentation, Aisel surfaces exactly what a clinician needs to make an informed decision, and shapes it into the report, note, or assessment the moment calls for. We dont deliver just a way to write things down faster, but rather enable clinicians to walk into every patient room with the full picture in front of them, so the judgement they bring is as informed as it can be. Built exclusively for psychiatry; we speak the language of the clinic and the real shape of a psychiatrists day - building for how care gets delivered. Built with psychiatrists, for psychiatry. Privacy-first, GDPR-compliant, and hosted entirely in the EU. Interested in exploring Aisel for your clinic? 👉 Register: www.aisel.co

Unither Pharmaceuticals, with 8 manufacturing plants (France, USA, Brazil and China) 4 commercial offices and 1 R&D platform, is the worldwide leader in sterile unit-doses contract manufacturing. Unither Pharmaceuticals manufactures several product lines, using highly innovative and competitive niche technologies such as: Liquid Stick-Pack, Sterile unit-dose (Blow Fill & Seal Technology), Multidoses with and without preservative, Pharmaceuticals bottles, Suppositories and Pessaries, etc. Our products are sold in more than 100 countries for an annual turnover of 371 million euros. Our vision is to be recognized for making affordable healthcare solutions that improve and simplify patients’ lives for as many people as possible. Our mission is to deliver innovative, competitive and sustainable solutions to our customers: pharmaceutical companies. Our promise is to consider patients’ needs in order to make successful products for our pharmaceutical customers.

Aisel Health - the clinical operating system for psychiatry Psychiatry doesnt have a caring problem. It has a capacity problem. Clinicians are buried in documentation and fragmented information, while patients wait months for care that should be available the moment they need it. Aisel closes that gap. We sit at the workflow layer around every consultation - recording, structuring notes, and pulling together the scattered pieces of a patients history into one clear, complete picture. From referrals and prior records to hundreds of pages of case documentation, Aisel surfaces exactly what a clinician needs to make an informed decision, and shapes it into the report, note, or assessment the moment calls for. We dont deliver just a way to write things down faster, but rather enable clinicians to walk into every patient room with the full picture in front of them, so the judgement they bring is as informed as it can be. Built exclusively for psychiatry; we speak the language of the clinic and the real shape of a psychiatrists day - building for how care gets delivered. Built with psychiatrists, for psychiatry. Privacy-first, GDPR-compliant, and hosted entirely in the EU. Interested in exploring Aisel for your clinic? 👉 Register: www.aisel.co

Keensight Capital (“Keensight”), one of the leading European Growth Buyout firms, is committed to supporting entrepreneurs as they implement their growth strategies. With over 25 years of experience and more than €8bn of assets under management, Keensight Capital’s team of seasoned professionals leverages their differentiated private equity experience to invest in profitably growing companies generating revenues in the range of €10 million to €400 million. Drawing on its expertise in the Technology and Healthcare sectors, Keensight identifies the best investment opportunities in Europe and works closely with the management teams providing capital, strategic guidance and operational support. Keensight operates in more than 90 countries across the globe with a presence in Paris, London, Boston, and Singapore.

Lauxera Capital Partners is an independent, international, healthcare-focused asset management company. Our growth equity investments focus primarily on commercial-stage medical devices, digital health, life sciences tools, and healthcare data companies. Led by entrepreneurial company builders and seasoned healthcare investors with experience across international markets, we empower European healthtech entrepreneurs to deliver the growth promised by their innovations. Lauxera was created in 2020 and has offices in Paris and San Francisco.